| Catalog_no |
ADMC1242 |
| Product_name |
Mivebresib(ABBV-075) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1660.00/5000.00/8340.00 |
| Specificity |
Target: c-Myc. Fields: Mivebresib is a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. |
| Dilution |
|
| Purification |
>98% |
| Concentration |
靶点：c-Myc;IC50：No data |
| Storage_stability |
4 Degree for 1 year, -20 degree for more than 2 years |
| othername |
ABBV-075; ABBV075; ABBV 075 |
| Molecular Weight |
459.47 |
| Notes |
Mivebresib is a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. |
| Instructions |
 查看与下载 |
